93 related articles for article (PubMed ID: 920909)
1. Treatment of digitalis toxicity with intravenous potassium canrenoate.
Gavrilescu G; Cristodorescu R; Deutsch G; Berger E
Agressologie; 1977; 18(3):167-71. PubMed ID: 920909
[No Abstract] [Full Text] [Related]
2. The effect of intravenous potassium canrenoate in patients with severe heart failure and digitalis toxicity.
Cristodorescu R; Puschita M; Deutsch G; Berger E; Luca C
Med Interne; 1977; 15(1):27-34. PubMed ID: 841250
[TBL] [Abstract][Full Text] [Related]
3. Canrenoate--a spironolactone metabolite. Acute cardiac effects in digitalized patients.
Waldorff S; Buch J
Eur J Cardiol; 1979 Aug; 10(2):143-9. PubMed ID: 477703
[TBL] [Abstract][Full Text] [Related]
4. [Use of canrenoate potassium given orally in ascitogenic cirrhosis].
Sarti F; Milandri GL; Piemontese A; Macchia S; Simoni S; Dal Monte PR
Minerva Dietol Gastroenterol; 1984; 30(3):273-80. PubMed ID: 6504377
[No Abstract] [Full Text] [Related]
5. [Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension].
Consolo F; Ferraù O; Pitrone F; Luzza G; Russo A; Virga T
Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1943-9. PubMed ID: 1231877
[No Abstract] [Full Text] [Related]
6. [The use of an injectable anti-aldosteron agent in the treatment of secondary hyperaldosteronism].
Tartagni F; Ambrosioni E
Boll Soc Ital Cardiol; 1976; 21(4):725-7. PubMed ID: 1031037
[No Abstract] [Full Text] [Related]
7. [Antihypertensive efficacy and effects on intra and extracellular electrolytes of a canrenoate potassium-butizide combination].
Costa FV; Borghi C; Mussi A; Ambrosioni E
Minerva Cardioangiol; 1988 Oct; 36(10):503-7. PubMed ID: 3226562
[No Abstract] [Full Text] [Related]
8. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
Tempini S; Bellati G; Ideo G
Minerva Dietol Gastroenterol; 1984; 30(3):255-61. PubMed ID: 6504374
[No Abstract] [Full Text] [Related]
9. [Study of the inotropic effect of potassium-canrenoate by systolic time intervals technique (author's transl)].
Vitolo E; Larovere MT; Gambini E; Rusconi F; Vitali GM
G Ital Cardiol; 1980; 10(10):1360-5. PubMed ID: 7239083
[TBL] [Abstract][Full Text] [Related]
10. [Effect of potassium canrenoate on arterial pressure, plasma renin activity and urinary aldosterone in essential hypertension].
Opocher G; Armanini D; Fallo F; Mantero F
Boll Soc Ital Cardiol; 1978; 23(10):1757-66. PubMed ID: 400390
[No Abstract] [Full Text] [Related]
11. [Efficacy of canrenoate potassium in hypertensive cardiopathy. Clinical and echocardiographic evaluation].
Caporicci D; Achilli L
Minerva Cardioangiol; 1984 Sep; 32(9):581-7. PubMed ID: 6514202
[No Abstract] [Full Text] [Related]
12. [Use of potassium canrenoate in cardiosurgery].
Tufano R; Scopa M; Brando G; Leone D
Minerva Anestesiol; 1981 Apr; 47(4):149-54. PubMed ID: 7242963
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic effect of canrenoate potassium (soldactone) in patients after open-heart surgery].
Matsuda K; Tatsuta N; Konishi Y; Minami K; Nishiwaki N; Yamasato A; Chiba Y; Ishihara H; Murata S; Shiraishi Y; Muraguchi T; Hikasa Y
Nihon Geka Hokan; 1982 May; 51(3):519-27. PubMed ID: 7138201
[No Abstract] [Full Text] [Related]
14. [Value of potassium canrenoate in the prevention of arrhythmia during the acute phase of myocardial infarction].
Denis B; Machecourt J; Denis MC; Morena H; Pellet J; Rossignol B; Martin-Noël P
Arch Mal Coeur Vaiss; 1979 Sep; 72(9):1014-22. PubMed ID: 116612
[TBL] [Abstract][Full Text] [Related]
15. [False values of blood digoxin in patients with acute and chronic liver disease. Role of canrenoate potassium and comparison of radioimmunologic and immunoenzymatic methods].
Nardoni A; di Piazza V; Moretti V; Copetti R; Trinco G; Geatti O
Clin Ter; 1988 May; 125(4):287-90. PubMed ID: 2974364
[No Abstract] [Full Text] [Related]
16. [Effect of canrenoate potassium on intraoperative disturbances of electrolyte equilibrium].
Eschner J; Fodor L; Ahnefeld FW
Infusionsther Klin Ernahr; 1976 Apr; 3(2):98-104. PubMed ID: 965083
[TBL] [Abstract][Full Text] [Related]
17. Antiarrhythmic activity of potassium canrenoate in man.
Yeh BK; Chiang BN; Sung PK
Am Heart J; 1976 Sep; 92(3):308-14. PubMed ID: 949026
[TBL] [Abstract][Full Text] [Related]
18. [Study of the inotropic effect of potassium canrenoate by determining systolic time intervals].
Vitolo E; Gambini E; Larovere MT; Rusconi F; Vitali GM
Boll Soc Ital Cardiol; 1979; 24(7):775-7. PubMed ID: 554665
[No Abstract] [Full Text] [Related]
19. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
Traina M; Vizzini GB
Minerva Med; 1986 Jan; 77(3-4):87-91. PubMed ID: 3511409
[TBL] [Abstract][Full Text] [Related]
20. [Changes in nitrogen balance during the period following abdominal surgery and use of an injectable anti-aldosterone].
Metivier Y; Guinot P; Saizy R; Meillaud J; Lioret N
Agressologie; 1976; 17(5):313-8. PubMed ID: 1015551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
